Convertible Notes: What Angel Investors Must Know Before They Sign

ByJeff Barnes, MBA

May 27, 2026·11 min read

Reviewed by Jeff Barnes — CEO of Angel Investors Network · MBA · $1B+ in Capital Formation

Convertible Notes: What Angel Investors Must Know Before They Sign

I watched a $250,000 angel check evaporate in 2019 because the investor never read the maturity clause on a convertible note. The company missed its Series A, the 18-month clock ran out, and that investor spent six months trying to negotiate an extension against a founder who had zero leverage to offer anything meaningful. The investor got a piece of paper, a lesson, and a tax loss. That is not how this is supposed to work.

Convertible notes remain the workhorse of bridge financing. According to Carta's platform data, they account for a meaningful share of bridge rounds even as SAFEs dominate pre-seed. I have deployed capital through convertible notes across more than 40 deals. I have seen them protect investors beautifully and detonate quietly. The difference almost always comes down to whether the investor understood what they signed.

What a Convertible Note Actually Is

A convertible note is a loan. That sentence matters more than any term sheet jargon. You are lending money to a startup, and that startup owes you principal plus interest. The note converts into equity under specific conditions — most often when the company raises a priced equity round above a defined threshold. Until that happens, you are a creditor, not an equity holder.

Four terms define every convertible note's economics:

Principal — the cash you invest. The baseline amount that converts or must be repaid.
Interest rate — typically 5% to 7% simple interest annually in the current market, per Kruze Consulting's Q1 2025 data. It accrues and converts alongside principal, increasing the share count at conversion.
Maturity date — the deadline. Standard notes run 18 to 24 months. If the company has not raised a qualifying round by then, the note is technically due. This is where most angel investors take a gut punch they did not see coming.
Qualified financing threshold — the trigger. Conversion only fires automatically when the company raises above a defined dollar amount in a priced equity round. Common thresholds range from $250,000 to $2 million. If they raise below that number, your note stays debt.

The Math That Actually Matters: Discount vs. Cap

Two mechanisms reward early investors at conversion: the discount rate and the valuation cap. They operate in the alternative — the investor gets whichever is more favorable, not both stacked together.

The Discount Rate

A 20% discount means your note converts at 80% of the price paid by new investors in the qualifying round. If Series A investors pay $2.00 per share, you convert at $1.60 per share. A $100,000 investment becomes 62,500 shares instead of 50,000 shares. The discount is straightforward but has a flaw: if the company explodes in value, a flat discount leaves substantial upside on the table.

The Valuation Cap

The cap is where the real investor protection lives. A valuation cap sets the maximum pre-money valuation at which your note converts, regardless of how high the company's actual Series A valuation lands.

Here is a concrete example. You invest $500,000 at a 5% annual interest rate with a $10 million valuation cap and a 20% discount. Twelve months later, the company raises a $5 million Series A at a $35 million pre-money valuation, priced at $2.00 per share.

Your principal plus accrued interest: $500,000 + $25,000 = $525,000

Now test both mechanisms:

Discount path: $35M pre-money × 80% = $28M effective valuation. Your price per share = $2.00 × 80% = $1.60.
Cap path: Your effective valuation = $10M cap. With 17.5 million pre-money shares outstanding, cap price = $10M ÷ 17.5M = $0.571 per share.

The cap is far more favorable. Your $525,000 converts at $0.571 per share, giving you approximately 919,000 shares. Series A investors pay $2.00 per share. Your effective discount to the Series A price is roughly 71%. That is the reward for writing a check before the risk was legible.

Cap negotiation is the only term I spend real energy on. A $5 million cap versus a $12 million cap on the same deal is the difference between a fund-returning position and an above-average return. Push on the cap. Accept almost anything else.

How Conversion Works at a Priced Round

When the qualifying financing closes, conversion is automatic under most well-drafted notes. The mechanics, as outlined by Cooley LLP's emerging companies practice: the company closes above the qualified financing threshold; principal plus accrued interest is totaled; cap price versus discounted price is compared and the more favorable applies; the note converts into the same class of preferred stock as new investors; you receive shares and become an equity holder with full preferred rights.

That sequence works cleanly when the company reaches a priced round. When it does not — that is the scenario to underwrite before you deploy a dollar.

The Risks Most Investors Never See Coming

Risk 1: Zombie Companies and Maturity Renegotiation

This is the most underappreciated risk in angel investing. A company hits month 18, the market is cold, the product has traction but not rocketship traction, and no institutional investor is ready to lead a Series A. The note matures. The company cannot pay. Now what?

In almost every real case, as documented by Startup Lawyer, investors extend the maturity date. They do not sue. They extend — often with a sweetener attached: a lower cap, a better discount, a warrant. The problem is you are now negotiating from weakness, at the worst possible moment, while the company drifts.

Zombie companies are real. I define a zombie as a startup growing too slowly to raise institutional money but not failing fast enough for founders to shut it down. Your note sits there accruing interest, perpetually in extension. I have seen notes extended three times over five years. That investor would have been better off with a clean loss at year two.

My rule: Never deploy into a convertible note unless I can accept total loss within 24 months. If the company has not hit inflection by then, the note is a hostage, not an investment.

Risk 2: Down Rounds Are Not the Windfall They Appear

A down round — company raises below the note's cap — sounds like automatic good news for investors. You capped at $10 million, they raised at $8 million, you convert there. Fine.

Except a down round signals distress. It triggers anti-dilution provisions for existing preferred stockholders. Weighted-average anti-dilution means earlier equity investors get more shares to offset the lower price. New investors have leverage. The cap table gets complicated, and your note conversion becomes one line in a restructuring negotiation you did not expect to be in.

Risk 3: Accrued Interest as a Hidden Dilution Multiplier

Founders overlook this. Sophisticated investors should not. A $200,000 note at 6% interest sitting for two years converts as $224,720 — not $200,000. That extra $24,720 converts into shares at your favorable price. It is free equity for you and additional dilution for the founder. Across a stack of three or four notes with different terms and interest rates, the dilution from accrued interest can be meaningful.

From the investor side, interest accrual is a feature. But per the Accounting Insights tax treatment guide, the IRS treats accrued-but-unpaid interest as Original Issue Discount (OID). You may owe tax on phantom income each year — income you have not received in cash — while you are still waiting for the note to convert. Track this and plan for it. Your accountant needs to know you hold convertible notes.

Risk 4: No Voting Rights Until Conversion

You are a creditor, not an equity holder. You have no board representation, no information rights (unless negotiated separately), and no vote on major decisions. If the company pivots, dilutes the cap table with a new option pool, or accepts a below-threshold acquisition offer, you may have no say. This is structural. Understand it before you sign.

Convertible Notes vs. SAFEs: Pick Your Poison Consciously

Y Combinator introduced the SAFE (Simple Agreement for Future Equity) in 2013 specifically to strip out the debt mechanics. No interest. No maturity date. No repayment obligation. According to SeedForge's 2026 analysis of Carta data, SAFEs now represent roughly 90% of US pre-seed rounds. That shift tells you where the market has moved.

The convertible note's maturity date is simultaneously its greatest investor protection and its greatest liability. Here is how I score the trade-off:

Convertible notes win when: you want leverage at maturity; you are doing a bridge between priced rounds; your fund mandate requires yield-bearing instruments; you need a specific forcing function toward a priced round.

SAFEs win when: the company is early and needs speed over structure; you want to avoid zombie maturity negotiations; you want cap table clarity for the next Series A lead who will diligence every instrument outstanding.

I default to SAFEs at pre-seed when the company is less than 12 months old. I reach for convertible notes on bridge rounds, when I want a maturity forcing function, or when the deal involves investors who need yield-bearing instruments for their fund mandate. WilmerHale's 2026 analysis on SAFE dilution mechanics makes a point that applies equally to notes: conversion math can hide real dilution. Model every possible cap table outcome before you sign either instrument.

Tax Treatment: Four Facts That Bite Investors

These are not tax advice — they are the minimum you must understand before walking into a meeting with your accountant.

OID creates phantom income. When your note accrues interest without paying cash — which is almost every convertible note — the IRS treats that accrued interest as Original Issue Discount. You owe ordinary income tax each year on interest not yet received. The company should issue Form 1099-OID. Do not wait for it. This phantom income also increases your basis in the note, which matters at conversion.

Conversion is mostly tax-free — but not entirely. Principal converting to equity is a non-taxable event. Your basis carries to the stock. However, per LegalClarity's IRC analysis, shares attributable to accrued interest are taxable as ordinary income the year of conversion. An unexpected bill can arrive precisely when you are celebrating a successful Series A.

QSBS clock starts at conversion, not signing. Section 1202 can exclude up to $10 million (or 10x basis) in capital gains from federal taxes if you hold qualifying stock for five years. That five-year clock starts when the stock is issued — at conversion — not when you signed the note. An 18-month note means five more years of hold after the priced round. Plan deliberately.

Section 1244 does not apply pre-conversion. If the company fails before converting, your loss is a capital loss, not an ordinary loss. Section 1244 ordinary loss treatment — up to $100,000 for married filers — requires holding actual stock. A note that never converted gives you no access to that benefit.

Jeff's Convertible Note Investor Checklist

Before I write any check into a convertible note, I work through this list.

Cap or walk. No valuation cap, no deal. Full stop.
Model both conversion paths. Run cap and discount calculations at $15M, $30M, and $75M pre-money Series A valuations. Know your ownership before signing.
Maturity must give real runway. If the company expects to raise in 14 months, insist on 24 months. Do not engineer your own negotiation crisis.
Nail the qualified financing threshold. A $2 million threshold sounds standard until they raise $1.8 million and your note stays debt. Get the exact dollar amount and instrument type in writing.
Model total converting amount, not just principal. Simple vs. compound interest, monthly vs. annual accrual — these differences affect every share count projection.
Read every MFN clause carefully. If the company later issues a note with a lower cap, that clause may pull your cap down automatically. Trace the chain before you sign.
Tell your accountant the year you sign. OID phantom income starts accruing day one. Do not discover this at tax time in year two.
Confirm QSBS eligibility at conversion. The five-year Section 1202 clock starts when stock is issued, not when you signed the note. Plan the hold period deliberately.
Define your write-off trigger in advance. If this company has not hit fundraising inflection by month 24, what is your plan? The zombie trap closes slowly. Decide early.
Negotiate information rights separately. The note gives you nothing. Add a side letter with quarterly financials if the check size warrants it.

The Bottom Line

The mechanics of a convertible note are learnable in an afternoon. What trips up investors is the gap between reading the document and understanding what it means when reality arrives — when the Series A slips six months, when the cap looks thin against actual traction, when the maturity date becomes a negotiation.

I have used convertible notes to write some of my best checks. I have also watched them become instruments of slow frustration when a company stalled between milestones. The note did not fail. The underwriting did.

Know your instrument. Model the math. Treat the maturity date like the countdown it is.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.

This article is for informational and educational purposes only and does not constitute investment, legal, or tax advice. Always consult a qualified financial advisor, attorney, or tax professional before making investment decisions.